Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
JCR Pharmaceuticals Co., Ltd. (JP:4552)
:4552
RESEARCH TOOLSreports
Holding JP:4552?
Track your performance easily
4552 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥466.00 - ¥1,106.00
Previous CloseN/A
Volume326.50K
Average Volume (3M)N/A
Market Cap
¥68.06B
Enterprise Value¥92.59B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.94
Next Earnings
Jan 31, 2025EPS Estimate
9.49Next Dividend Ex-Date
Mar 28, 2025Dividend Yield3.64%
Share Statistics
EPS (TTM)-3.49
Shares Outstanding129,686,310
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥630.00Price Target Upside12.30% Upside
Rating ConsensusHold
Number of Analyst Covering2
JCR Pharmaceuticals Co., Ltd. News
PremiumCompany Announcements
JCR Pharmaceuticals to Showcase Innovative Therapies at WORLDSymposium 2025
PremiumCompany Announcements
JCR Pharmaceuticals and Modalis Advance Joint Gene Therapy ResearchPremiumCompany Announcements
JCR Pharmaceuticals Gains Orphan Drug Status in Japan
PremiumCompany Announcements
JCR Pharmaceuticals Launches Key JR-142 Clinical Trial
PremiumCompany Announcements
JCR Pharmaceuticals Initiates Clinical Trial for MPS IIIB
PremiumCompany Announcements
JCR Pharmaceuticals Faces Financial Decline Amid Strategic Changes
PremiumCompany Announcements
JCR Pharmaceuticals Completes Share Buyback for Strategic GrowthOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
1.39% Mutual Funds
― Other Institutional Investors
96.56% Public Companies and
Individual Investors
4552 FAQ
What was JCR Pharmaceuticals Co., Ltd.’s price range in the past 12 months?
JCR Pharmaceuticals Co., Ltd. lowest stock price was ¥466.00 and its highest was ¥1106.00 in the past 12 months.
What is JCR Pharmaceuticals Co., Ltd.’s market cap?
JCR Pharmaceuticals Co., Ltd.’s market cap is ¥68.06B.
When is JCR Pharmaceuticals Co., Ltd.’s upcoming earnings report date?
JCR Pharmaceuticals Co., Ltd.’s upcoming earnings report date is Jan 31, 2025 which is tomorrow.
How were JCR Pharmaceuticals Co., Ltd.’s earnings last quarter?
JCR Pharmaceuticals Co., Ltd. released its earnings results on Oct 30, 2024. The company reported -¥7.14 earnings per share for the quarter, missing the consensus estimate of ¥13.72 by -¥20.86.
Is JCR Pharmaceuticals Co., Ltd. overvalued?
According to Wall Street analysts JCR Pharmaceuticals Co., Ltd.’s price is currently Undervalued.
Does JCR Pharmaceuticals Co., Ltd. pay dividends?
JCR Pharmaceuticals Co., Ltd. pays a Annually dividend of ¥20 which represents an annual dividend yield of 3.64%. See more information on JCR Pharmaceuticals Co., Ltd. dividends here
What is JCR Pharmaceuticals Co., Ltd.’s EPS estimate?
JCR Pharmaceuticals Co., Ltd.’s EPS estimate is 9.49.
How many shares outstanding does JCR Pharmaceuticals Co., Ltd. have?
JCR Pharmaceuticals Co., Ltd. has 129,686,310 shares outstanding.
What happened to JCR Pharmaceuticals Co., Ltd.’s price movement after its last earnings report?
JCR Pharmaceuticals Co., Ltd. reported an EPS of -¥7.14 in its last earnings report, missing expectations of ¥13.72. Following the earnings report the stock price went down -0.305%.
Which hedge fund is a major shareholder of JCR Pharmaceuticals Co., Ltd.?
Currently, no hedge funds are holding shares in JP:4552
---
Technical Analysis
Astellas Pharma
―
Chugai Pharmaceutical Co
―
Eisai Co
―
Shionogi & Co
―
Takeda Pharmaceutical Co
―
---